Lineweaver Wealth Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.53M	Buy	3,048 +126	+4%	+$60.5K	0.18%	101
2026 Q1	$1.44M	Sell	2,922 -108	-4%	-$58.6K	0.19%	95
2025 Q4	$1.76M	Buy	3,030 +39	+1%	+$22.1K	0.24%	81
2025 Q3	$1.45M	Sell	2,991 -94	-3%	-$43.8K	0.21%	88
2025 Q2	$1.25M	Sell	3,085 -178	-5%	-$74.4K	0.2%	86
2025 Q1	$1.62M	Buy	3,263 +71	+2%	+$38.5K	0.28%	75
2024 Q4	$1.66M	Buy	3,192 +1,568	+97%	+$862K	0.31%	64
2024 Q3	$1.01M	Sell	1,624 -28	-2%	-$16.6K	0.19%	83
2024 Q2	$914K	Buy	1,652 +58	+4%	+$33.2K	0.19%	83
2024 Q1	$927K	Sell	1,594 -6	-0.4%	-$3.37K	0.22%	83
2023 Q4	$850K	Sell	1,600 -87	-5%	-$42.1K	0.22%	82
2023 Q3	$854K	Buy	1,687 +21	+1%	+$11.2K	0.25%	67
2023 Q2	$869K	Sell	1,666 -16	-1%	-$8.63K	0.25%	69
2023 Q1	$970K	Sell	1,682 -9	-0.5%	-$5.07K	0.3%	65
2022 Q4	$931K	Sell	1,691 -71	-4%	-$37.6K	0.28%	69
2022 Q3	$891K	Buy	1,762 +75	+4%	+$42K	0.29%	62
2022 Q2	$916K	Sell	1,687 -1,138	-40%	-$626K	0.3%	59
2022 Q1	$1.67M	Buy	2,825 +55	+2%	+$31.6K	0.48%	42
2021 Q4	$1.85M	Sell	2,770 -49	-2%	-$30.6K	0.53%	34
2021 Q3	$1.61M	Buy	2,819 +1,198	+74%	+$658K	0.49%	37
2021 Q2	$818K	Buy	1,621 +34	+2%	+$16K	0.27%	56
2021 Q1	$724K	Buy	1,587 +322	+25%	+$154K	0.26%	53
2020 Q4	$589K	Buy	1,265 +103	+9%	+$48.3K	0.23%	49
2020 Q3	$513K	Buy	1,162 +145	+14%	+$59.9K	0.23%	51
2020 Q2	$368K	Buy	1,017 +84	+9%	+$28.2K	0.19%	54
2020 Q1	$272K	Buy	+933	New	+$294K	0.17%	60

Other funds holding TMO